Mark Mallon - Dec 30, 2021 Form 4 Insider Report for NEOGENOMICS INC (NEO)

Role: Chief Executive Officer, Director
Signature: /s/ Mark W. Mallon
Stock symbol: NEO
Transactions as of: Dec 30, 2021
Transactions value $: $0
Form type: 4
Date filed: 12/30/2021, 05:05 PM
Previous filing: Dec 6, 2021
Next filing: Mar 3, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	NEO	Common Stock	Award	$0	+153K	+210.15%	$0.00	226K	Dec 30, 2021	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	NEO	Stock Option (Right to Buy)						151K	Dec 30, 2021	Common Stock	151K	$49.34	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On December 30, 2021, Mr. Mallon was granted 152,858 restricted stock awards. These awards vest ratably over three years with the first tranche vesting on December 31, 2022.
F2	On April 19, 2021, Mr. Mallon was granted 151,016 stock options. These options vest ratably over the first four anniversary dates of the grant date.